Boston Scientific Shows Me

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

I recently called Boston Scientific (NYSE: BSX  ) a "show-me company," suggesting you wait for the turnaround to happen before investing rather than trying to hit the ever-elusive bottom. Beating analysts' expectations, raising earning guidance, and announcing plans to repurchase shares? That's certainly a step in the right direction.

The top-line wasn't pretty though. Revenue was up just 2% and that was entirely due to a weaker dollar. At constant currency, revenue dropped 2%. Heart devices are still a weak market as we saw with St. Jude Medical (NYSE: STJ  ) last week.

Boston Scientific should benefit in the coming months from Johnson & Johnson's (NYSE: JNJ  ) announcement that it will exit the drug-eluting stent business, but it'll still have competition from Medtronic (NYSE: MDT  ) and Abbott Labs (NYSE: ABT  ) .

With cost cutting measures in effect and more planned, the bottom line looks much better. Boston Scientific increased adjusted earnings guidance to $0.64 to $0.70 per share for 2011, up from earlier guidance of $0.58 to $0.68 per share.

The medical-device maker plans to repurchase $1 billion worth of its shares, which is 9% of the outstanding shares at the current market cap. The buyback should help create a floor in the share price, but more importantly, it gives investors confidence that management is comfortable with its cash flow and debt level. The company recently brought its long-term debt down to $4.2 billion after it ballooned up after the over-priced purchase of Guidant.

Boston Scientific is trading 44% higher than its 52-week low, but at $7.28, it's also a long way from its all-time high in 2004, when it peaked over $40 per share. The company has shown it can hit its mark for at least one quarter. If that has you convinced, go ahead and buy, but waiting to see if this comeback has legs continues to seem like a sensible option. In the meantime, add it to your watchlist to follow along.

Fool contributor Brian Orelli holds no position in any company mentioned. Click here to see his holdings and a short bio. The Motley Fool owns shares of Medtronic, Johnson & Johnson, St. Jude Medical, and Abbott Laboratories. Motley Fool newsletter services have recommended buying shares of Johnson & Johnson and Abbott Laboratories. Motley Fool newsletter services have recommended creating a diagonal call position in Johnson & Johnson. 

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1528335, ~/Articles/ArticleHandler.aspx, 10/24/2016 3:05:06 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,226.86 81.15 0.45%
S&P 500 2,150.71 9.55 0.45%
NASD 5,303.70 46.30 0.88%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 2:49 PM
BSX $22.93 Up +0.11 +0.46%
Boston Scientific CAPS Rating: ***
ABT $40.36 Down -0.14 -0.35%
Abbott Laboratorie… CAPS Rating: *****
JNJ $113.65 Up +0.21 +0.19%
Johnson and Johnso… CAPS Rating: ****
MDT $83.34 Down -0.57 -0.68%
Medtronic CAPS Rating: *****
STJ $79.41 Up +0.05 +0.06%
St. Jude Medical CAPS Rating: **